Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2009
03/26/2009US20090081645 Method of assuming drug sensitivity to cdk4 inhibitor
03/26/2009US20090081644 Ligation amplification
03/26/2009US20090081643 Methods for evaluating ribonucleotide sequences
03/26/2009US20090081642 Novel apoptosis gene EI24, compositions, and methods of use
03/26/2009US20090081641 Methods and systems for treating disease
03/26/2009US20090081640 Methods of using miRNA for detection of in vivo cell death
03/26/2009US20090081639 Assay for sensitivity to chemotherapeutic agents
03/26/2009US20090081638 Immobilisation of Antigenic Carbohydrates to Support Detection of Pathogenic Microorganisms
03/26/2009US20090081637 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development
03/26/2009US20090081636 Pharmaceutical compositions for and methods of inhibiting HCV replication
03/26/2009US20090081635 Modified heparinase iii and methods of sequencing therewith
03/26/2009US20090081634 Fluorescent and saccharidic substrates, their process of preparation and their use
03/26/2009US20090081633 Seed testing method and apparatus
03/26/2009US20090081252 Decreasing potential iatrogenic risks associated with influenza vaccines
03/26/2009US20090081245 Assays for development of boris mutants suitable for vaccine development and small molecule inhibitors of wild-type boris
03/26/2009US20090081243 Agents and methods for diagnosing stress
03/26/2009US20090081237 Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents
03/26/2009US20090081229 Anti-pro87299 antibodies
03/26/2009US20090081226 Soluble HLA-E Molecules And Their Use For Diagnosing And Treating Pathologies
03/26/2009US20090081222 Novel splice variants of the egf receptor
03/26/2009US20090081215 Genetic products differentially expressed in tumors and use thereof
03/26/2009US20090081214 Genetic products differentially expressed in tumors and use thereof
03/26/2009US20090081209 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins
03/26/2009US20090081197 Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of Obesity
03/26/2009US20090081195 Inhibitors of Ste20-like Kinase (SLK) and Methods of Modulating Cell Cycle Progression and Cell Motility
03/26/2009US20090081192 Methods of screening for compounds having anti-inflammatory activity
03/26/2009US20090081189 Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells
03/26/2009US20090081173 Methods and compositions involving bacteriophage isolates
03/26/2009US20090081170 Cardiac progenitor cells
03/26/2009US20090081159 Compositions and methods for detecting and treating ophthalmic disorders
03/26/2009US20090081129 Bioluminescent Endoscopy Methods And Compounds
03/26/2009US20090081125 Angiogenetic Agent Containing Adrenomedulin as the Active Ingredient
03/26/2009US20090081124 Virus coat protein/receptor chimeras and methods of use
03/26/2009US20090078586 Small Volume In Vitro Analyte Sensor
03/26/2009US20090078574 Charge tags and the separation of nucleic acid molecules
03/26/2009CA2803927A1 Microfluidic device and method for fluid clotting time determination
03/26/2009CA2711818A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening
03/26/2009CA2705306A1 Neoepitope detection of disease using protein arrays
03/26/2009CA2700265A1 Compositions and methods for altering the morphology of plants
03/26/2009CA2700200A1 Identification of novel pathways for drug development for lung disease
03/26/2009CA2700125A1 Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast
03/26/2009CA2700082A1 Nucleobase characterisation
03/26/2009CA2699958A1 Identification and isolation of fetal cells and nucleic acid
03/26/2009CA2699860A1 Cardiomyocyte-like cell clusters derived from hbs cells
03/26/2009CA2699859A1 Compositions and methods for the identification of inhibitors of retroviral infection
03/26/2009CA2699856A1 Improved methylation detection
03/26/2009CA2699853A1 Improved detection of mage-a expression
03/26/2009CA2699828A1 Method for measuring substrate concentration and device for the same
03/26/2009CA2699760A1 Compositions and methods for diagnosis and treatment of type 2 diabetes
03/26/2009CA2699606A1 Novel markers for bladder cancer detection
03/26/2009CA2699569A1 Hydrogel labeled primer extension method for microarrays
03/26/2009CA2699518A1 Supramolecular nanostamping printing device
03/26/2009CA2699315A1 Self-actuating signal producing detection devices and methods
03/26/2009CA2698397A1 Method of conferring a protective immune response to norovirus
03/26/2009CA2698390A1 A rapid and sensitive method for detection of biological targets
03/26/2009CA2697640A1 Tools and methods for genetic tests using next generation sequencing
03/26/2009CA2697532A1 Method of amplifying nucleic acid
03/26/2009CA2694494A1 Hpiv-2 variants and medical applications thereof
03/26/2009CA2688558A1 Biomarker combinations for colorectal cancer
03/26/2009CA2670019A1 Methods, systems, and compositions for cancer diagnosis
03/25/2009EP2040187A1 Gene information processing apparatus and gene information display apparatus
03/25/2009EP2040078A1 Method for quantifying phosphokinase activity on proteins
03/25/2009EP2040068A2 Nucleic acid detection sensor
03/25/2009EP2040065A1 Method and apparatus for measuring liquid sample
03/25/2009EP2039782A2 Method and apparatus for judging the presence or absence of cancer cell
03/25/2009EP2039781A1 Displacement assay for detecting nucleic acid oligomer hybridisation events
03/25/2009EP2039780A1 Single-readout multiplexing of metagenes
03/25/2009EP2039779A1 Screening method
03/25/2009EP2039778A2 Article and method for detection of enterotoxigenic staphylococci
03/25/2009EP2039769A2 Antimicrobial peptides and methods of use
03/25/2009EP2039765A1 Method for determination of 1,5-anhydroglucitol, and reagent composition for determination of 1,5-anhydroglucitol
03/25/2009EP2039762A2 Nitralases
03/25/2009EP2039755A2 Device and methods for detecting microorganisms
03/25/2009EP2039367A1 Prophylactic/therapeutic agent for neurodegenerative disease
03/25/2009EP2038651A2 An in vitro method of detecting and/or diagnosing cancer using uv light based dna image cytometry
03/25/2009EP2038432A2 A method for detecting nucleic acids
03/25/2009EP2038431A1 Method for determining preeclampsia risk
03/25/2009EP2038430A1 Toll like receptor 4 dysfunction and the biological applications thereof
03/25/2009EP2038428A1 Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase
03/25/2009EP2038427A2 Single-molecule pcr on microparticles in water-in-oil emulsions
03/25/2009EP2038425A1 High throughput physical mapping using aflp
03/25/2009EP2038416A1 Nitrogen limitation adaptibility gene and protein and modulation thereof
03/25/2009EP2038415A1 Dph2 gene deletion mutant and uses thereof
03/25/2009EP2038409A2 Novel human acidic mammalian chitinase and use thereof
03/25/2009EP2037948A2 Detecting and treating dementia
03/25/2009EP2037945A2 Permeability of blood-brain barrier
03/25/2009EP1920239A4 Detection and measurement of blood-feeding activity
03/25/2009EP1910549A4 Analyzing messenger rna and micro rna in the same reaction mixture
03/25/2009EP1899725A4 Nucleic acid biosensor with photoelectrochemical amplification
03/25/2009EP1888775A4 Method for measuring effectively the activity of cytotoxic t lymphocyte in human and out-bred animals
03/25/2009EP1859050A4 A method for the detection of chromosomal aneuploidies
03/25/2009EP1856503A4 Dual path immunoassay device
03/25/2009EP1815022A4 Method of determining a cellular response to a biological agent
03/25/2009EP1766401B1 Method for the simple and rapid detection of cells and biomolecules by means of paramagnetic particles
03/25/2009EP1711808A4 Method for measurement of immature granulocytes
03/25/2009EP1641810A4 Prediction of likelihood of cancer recurrence
03/25/2009EP1633888B1 Means and method for the detection of target nucleotide sequences using ligation assays with improved oligonucleotide probe pairs
03/25/2009EP1633854B1 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
03/25/2009EP1615942A4 Polymerase inhibitor and method of using same
03/25/2009EP1551627A4 Method and composition for forming a protective coating on an assay substrate and substrate produced by the same